Sign inJoin waitlistJoin the waitlist

Miriam Cremer

Professor, Department of Obstetrics and Gynecology, School of Medicine · Case Western Reserve University

Credentials: · · · · · · ·

History

Case Western Reserve University
Present
Cleveland Clinic Foundation
Present

Complex Family Planning
University of Southern California/Los Angeles General Medical Center
2003–2005
New York University Downtown Hospital
2000–2003
Obstetrics and Gynecology
University of Wisconsin Hospitals and Clinics
1999–2000
Cambridge Hospital
1998–1999
Johns Hopkins Bloomberg School of Public Health
University of Wisconsin School of Medicine and Public Health
1993–1997
Hampshire, College
1988–1992

Research

Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador
International Journal of Gynecology & Obstetrics · 2014 · Last of 11 authors · Corresponding · 59 citations
Removing global barriers to cervical cancer prevention and moving towards elimination
Nature reviews. Cancer · 2021 · 58 citations
Cervical Precancer Treatment in Low- and Middle-Income Countries: A Technology Overview
Review · Journal of Global Oncology · 2017 · Last of 5 authors · Corresponding · 48 citations

Juan Felix
30 papers
Rachel Masch
26 papers
Kathleen Schmeler
5 papers
Mark Einstein
4 papers
KD
Kanan Desai
3 papers · 1 as a resident
KB
Kimberley Bullard
3 papers
Preetha Ramalingam
3 papers
Adam Jacobs
2 papers
Akiva Novetsky
2 papers
AR
Alan Rosenbaum
2 papers · 1 as a resident
Bari Laskow
2 papers · 2 as a resident
Beatrice Chen
2 papers

Grants

CHAMP: Cervical Cancer Prevention Using HPV Testing with a Mobile Testing Platform
National Cancer Institute · R01
Contact PI · $574.1K · Cleveland Clinic Lerner Com-Cwru
2026–2031
Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)
National Cancer Institute · R01
Contact PI · $2.9M · Cleveland Clinic Lerner Com-Cwru
2022–2027
PROGRESS: PRevention of Cervical Cancer Using the Genotyping scREening and Same-Day Self-Sampling
National Cancer Institute · R44
PI · $2M · Atila Biosystems, Inc.
2022–2025
Comparison of Cervical Intraepithelial Neoplasia 2/3 Treatment Outcomes with a Portable LMIC-Adapted Thermal Ablation Device vs. Gas-Based Cryotherapy
National Cancer Institute · R01
Contact PI · $3.7M · Cleveland Clinic Lerner Com-Cwru
2018–2025

Clinical trials

Introducing a Telemedicine Strategy to Deliver Cervical Cancer Screening Results in El Salvador
Principal investigator · Completed
The Cleveland Clinic
2024
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device
Principal investigator · Completed
The Cleveland Clinic
2020–2025
An Innovative Treatment for Cervical Precancer (UH3)
Principal investigator · Completed
The Cleveland Clinic
2017–2024
An Innovative Treatment for Cervical Pre Cancer
Principal investigator · Completed
The Cleveland Clinic
2016